Greenberg Traurig Congratulates 2 IP Clients on Winning 2024 BIPLA ‘Invented Here!’ Awards
PRNewswire-PRWeb/ — Global law firm Greenberg Traurig, LLP’s Boston Intellectual Property (IP) & Technology Practice congratulates two of its …
GLOBAL IP NEWS
-
In: PATENT NEWS
-
In: TRADEMARK NEWS
Mike Murphy Co-Creator of TextTonality Trademark Interviewed on the Influential Entrepreneur Podcast – openPR
Mike Murphy Co-Creator of TextTonality Trademark Interviewed on the Influential Entrepreneur Podcast openPR
-
In: PATENT NEWS
Perspectives from the ABPI (Brazilian Intellectual Property Association) Forum on AI and IP
The forum brought together a diverse group of stakeholders: IP rightsholders, technology companies, researchers, and legal practitioners to explore …
-
In: PATENT NEWS
Patent Litigation in Canada and India: A Comparative Summary – Lexology
… legislation. Strong intellectual property rights create a legal framework that allows businesses to protect their innovations, maintain …
-
In: PATENT NEWS
Nippon Shinyaku Owes Sarepta $115 Million on Gene-Therapy Patent – Bloomberg Law
Nippon Shinyaku Owes Sarepta $115 Million on Gene-Therapy Patent Bloomberg Law
-
In: PATENT NEWS
Latham & Watkins Successfully Defend Patents at the ITC for Cosmetic Devices – Law.com
Latham & Watkins Successfully Defend Patents at the ITC for Cosmetic Devices Law.com
-
In: PATENT NEWS
Latham & Watkins Successfully Defend Patents at the ITC for Cosmetic Devices – Law.com
What You Need to Know · Serendia Inc. succeeded in defending four patents used for radio frequency microneedling devices. · An administrative law judge …
-
In: TRADEMARK NEWS
Lenexa-based catnip provider sues competitor over copycat brands – The Business Journals
Lenexa-based catnip provider sues competitor over copycat brands The Business Journals
-
In: PATENT NEWS
The IP Advocate – Accesswire
He later le‑ Bateman IP to serve as the chair of intellectual property groups for two of Salt Lake City’s largest law firms. He then returned to …
-
In: PATENT NEWS
Teva loses US appeal to keep inhaler patents on FDA protected drug list – Reuters.com
Teva loses US appeal to keep inhaler patents on FDA protected drug list Reuters.com